Location History:
- Los Altos, CA (US) (1996 - 2001)
- Cupertino, CA (US) (2009)
Company Filing History:
Years Active: 1996-2009
Title: K Jin Kim: Innovator in Monoclonal Antibody Development
Introduction
K Jin Kim is a prominent inventor based in Los Altos, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to his name, Kim's work has had a substantial impact on medical research and therapeutic applications.
Latest Patents
One of K Jin Kim's latest patents is a method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method. This innovative approach describes a mixed antigen immunization protocol for producing monoclonal antibodies. The antibodies generated by this method are capable of specifically cross-reacting with two or more different receptors to which Apo-2 ligand (Apo-2L) can bind. This advancement holds promise for enhancing the efficacy of therapeutic antibodies in various medical applications.
Career Highlights
Throughout his career, K Jin Kim has worked with notable companies in the biotechnology sector, including Genentech, Inc. and Genetech, Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and contribute to groundbreaking research.
Collaborations
K Jin Kim has collaborated with several talented individuals in his field, including Anan Chuntharapai and James M Lee. These partnerships have fostered innovation and have been instrumental in advancing the research and development of monoclonal antibodies.
Conclusion
K Jin Kim's contributions to the field of monoclonal antibody development are noteworthy. His innovative methods and collaborations have positioned him as a key figure in biotechnology. His work continues to influence the landscape of medical research and therapeutic advancements.